Yonggeun Hong

Prof. Dr. Yonggeun Hong

Department of Physical Therapy, College of Healthcare Medical Science & Engineering, Biohealth Products Research Center (BPRC), u-Healthcare & Anti-aging Research Center (u-HARC), Inje University, South Korea
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BKByeong Mo Kim
Byeong Mo Kim
YHYunkyung Hong
Yunkyung Hong
SLSenghoon Lee
Senghoon Lee
PLPengda Liu
Pengda Liu
JLJi-Hong Lim
Ji-Hong Lim
Yonggeun HongYonggeun Hong
Yonggeun Hong
Ionizing radiation (IR), such as X-rays and gamma (γ)-rays, mediates various forms of cancer cell death such as apoptosis, necrosis, autophagy, mitotic catastrophe, and senescence. Among them, apoptosis and mitotic catastrophe are the main mechanisms of IR action. DNA damage and genomic instability contribute to IR-induced cancer cell death. Although IR therapy may be curative in a number of cancer types, the resistance of cancer cells to radiation remains a major therapeutic problem. In this review, we describe the morphological and molecular aspects of various IR-induced types of cell death. We also discuss cytogenetic variations representative of IR-induced DNA damage and genomic instability. Most importantly, we focus on several pathways and their associated marker proteins responsible for cancer resistance and its therapeutic implications in terms of cancer cell death of various types and characteristics. Finally, we propose radiation-sensitization strategies, such as the modification of fractionation, inflammation, and hypoxia and the combined treatment, that can counteract the resistance of tumors to IR.

31 January 2014 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
YHYunkyung Hong
Yunkyung Hong
JWJinyoung Won
Jinyoung Won
YLYoungjeon Lee
Youngjeon Lee
SLSeunghoon Lee
Seunghoon Lee
KPKanghui Park
Kanghui Park
Yonggeun HongYonggeun Hong
Yonggeun Hong

18 March 2026 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
SASharmin Akter
Sharmin Akter
MRMadhuvilakku Rajesh
Madhuvilakku Rajesh
AKAnik Kumar Kar
Anik Kumar Kar
INIrin Sultana Nila
Irin Sultana Nila
Pengda LiuPengda Liu
Pengda Liu
Yonggeun HongYonggeun Hong
Yonggeun Hong
Reactive oxygen species (ROS) act as critical secondary messengers in various intracellular signaling pathways that regulate cellular proliferation, differentiation, and survival under normal physiological conditions. However, dysregulation of redox signaling—driven by genetic mutations, epigenetic alterations, and posttranscriptional or posttranslational modifications—plays a central role in malignant transformation and cancer progression. Cancer cells typically exhibit elevated basal ROS levels due to increased metabolic activity, mitochondrial dysfunction, and oncogene activation. This moderate oxidative stress promotes tumorigenesis by inducing DNA damage, genomic instability, and aberrant activation of proliferative and survival pathways, while also contributing to resistance to conventional therapies. Paradoxically, excessive ROS accumulation can overwhelm antioxidant defenses, triggering oxidative stress-induced programmed cell death (PCD) mechanisms, including apoptosis, autophagy, and ferroptosis. Owing to its dual role—facilitating both tumor progression and suppression—ROS have emerged as compelling yet complex targets in cancer therapy. Therapeutic strategies aimed at modulating ROS homeostasis, such as enhancing ROS production, inhibiting antioxidant systems, or targeting downstream redox-regulated signaling nodes, hold promise for selectively eliminating cancer cells. Furthermore, integrating redox profiling or “redox signatures” into personalized medicine approaches may optimize therapeutic efficacy while minimizing off-target toxicity. In this review, we critically examine the Janus-faced role of ROS in carcinogenesis, dissect the molecular pathways regulated by ROS in tumor biology, and explore current advancements, limitations, and future directions in redox-based anticancer therapeutic approaches.

15 February 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Jeonghyun ChoiJeonghyun Choi
Jeonghyun Choi
SLSeunghoon Lee
Seunghoon Lee
JWJinyoung Won
Jinyoung Won
YJYunho Jin
Yunho Jin
YHYunkyung Hong
Yunkyung Hong
Yonggeun HongYonggeun Hong
Yonggeun Hong
Autism spectrum disorder (ASD) is induced by complex hereditary and environmental factors. However, the mechanisms of ASD development are poorly understood. The purpose of this study was to identify standard indicators of this condition by comparing clinical, pathophysiological, and neurobehavioral features in an autism-like animal model. A total of 22 male Sprague-Dawley rats were randomly divided into control and 500 mg/kg propionic acid (PPA)-treated groups. Rats were subjected to behavioral tests, gene expression analyses, and histological analyses to detect pathophysiological and neurobehavioral alterations. Exploratory activity and non-aggressive behavior were significantly reduced in PPA-treated rats, whereas enhanced aggressive behavior during adjacent interactions was observed on day 14 after PPA administration. To evaluate gene expression after PPA administration, we analyzed hippocampal tissue using reverse transcription PCR. Glial fibrillary acidic protein was augmented in the PPA-treated group on day 14 after appearance of ASD-like behaviors by PPA administration, whereas octamer-binding transcription factor 4 expression was significantly decreased in the PPA-treated group. Histological evaluation revealed significantly reduced diameter and layer thickness of granule cells in PPA-treated rats compared with control rats. We conclude that PPA administration induced abnormal neural cell organization, which may have led to autism-like neurobehaviors, including increased aggressive behavior, reduced exploratory activity, and isolative and passive behaviors.

1 August 2021 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
Dewan Md. SumsuzzmanDewan Md. Sumsuzzman
Dewan Md. Sumsuzzman
Jeonghyun ChoiJeonghyun Choi
Jeonghyun Choi
YJYunho Jin
Yunho Jin
Yonggeun HongYonggeun Hong
Yonggeun Hong
Endogenous melatonin levels are inversely associated with age and cognitive deficits. Although melatonin can improve psychopathological behavior disturbances in clinical trials, whether melatonin may also enhance cognitive function remains elusive. This study examined cognitive outcomes from randomized trials of melatonin treatment for Alzheimer's disease (AD), insomnia, and healthy-subjects. Twenty-two studies met the inclusion criteria (AD = 9, insomnia = 2, healthy-subjects = 11). AD patients receiving >12 weeks of melatonin treatment improved mini-mental state examination (MMSE) score [MD: 1.82 (1.01; 2.63) p < 0.0001]. Importantly, melatonin significantly improved MMSE score in mild stage of AD [MD: 1.89 (0.96; 2.82) p < 0.0001]. In healthy-subjects, although daytime melatonin treatment notably decreased in accuracy by correct responses [SMD: -0.74 (-1.03; -0.45) p < 0.00001], the reaction-time score on different stimuli (p = 0.37) did not increased. Additionally, by pooling of short-term, spatial, and visual memory scores, melatonin did not reduce memory function (p = 0.08). Meta-analysis of MMSE score suggested that melatonin is effective in treatment for mild stage of AD. Additionally, we propose that melatonin may be preferable to traditional hypnotics in management of insomnia.

1 January 2015 in Journal of Physical Therapy Science
Verified
Journal Article
Open access
MLMinkyung Lee
Minkyung Lee
YHYunkyung Hong
Yunkyung Hong
SLSeunghoon Lee
Seunghoon Lee
JWJinyoung Won
Jinyoung Won
JYJinjun Yang
Jinjun Yang
Yonggeun HongYonggeun Hong
Yonggeun Hong
[Purpose] The purpose of this study was to determine whether muscle activity and pressure-induced pain in the upper extremities are affected by smartphone use, and to compare the effects of phone handling with one hand and with both hands. [Subjects] The study subjects were asymptomatic women 20-22 years of age. [Methods] The subjects sat in a chair with their feet on the floor and the elbow flexed, holding a smartphone positioned on the thigh. Subsequently, the subjects typed the Korean anthem for 3 min, one-handed or with both hands. Each subject repeated the task three times, with a 5-min rest period between tasks to minimize fatigue. Electromyography (EMG) was used to record the muscle activity of the upper trapezius (UT), extensor pollicis longus (EPL), and abductor pollicis (AP) during phone operation. We also used a dolorimeter to measure the pressure-induced pain threshold in the UT. [Results] We observed higher muscle activity in the UT, AP, and EPL in one-handed smartphone use than in its two-handed use. The pressure-induced pain threshold of the UT was lower after use of the smartphone, especially after one-handed use. [Conclusion] Our results show that smartphone operation with one hand caused greater UT pain and induced increased upper extremity muscle activity.